Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability

Journal of the American College of Cardiology

Volumn 34, Issue 2, 1999, Pages 507-514

  Prasad, Abhiram ^a   Andrews, Neil P ^a   Padder, Feroz A ^a   Husain, Mohsin ^a   Quyyumi, Arshed A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; GLUTATHIONE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; FEMORAL ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ARTERIOSCLEROSIS; BLOOD FLOW VELOCITY; CYCLIC GMP; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; NITROPRUSSIDE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0032698871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00216-8     Document Type: Article

References (43)

1. Rubyani C.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 22:(Suppl 4):1993;S1-S14.
2. Ross R. The pathogenesis of atherosclerosis: a prospective for the 1990s. Nature. 362:1993;801-809.
3. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
4. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
5. Cosentino F., Hishikawa K., Katusic Z.S., Lüscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 96:1997;25-28.
6. Barnes P.J., Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1997;1066-1071.
7. Stamler J.S., Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev. 54:1996;1-30.
8. Myers P.R., Minor R.L. Jr, Guerra R. Jr, et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
9. Keaney J.F. Jr, Simon D.I., Stamler J.S., et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest. 91:1993;1582-1589.
10. Scharfstein J., Keaney J.F. Jr, Slivka A., et al. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low-molecular weight thiols. J Clin Invest. 94:1994;1432-1439.
11. Lapenna D., de Gioia S., Ciofani G., et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation. 97:1998;1930-1934.
12. Morrison J.A., Jacobsen D.W., Sprecher D.L., et al. Serum homocysteine, glutathione and risk of coronary heart disease in adolescent males. Circulation. 96:1997;I-101.
13. Aucoin M.M., Barhoumi R., Kochevar D.T., et al. Oxidative injury of coronary venular endothelial cells depletes intracellular glutathione and induces HSP 70mRNA. Am J Physiol. 268:1995;H1651-H1658.
14. Cooke J.P., Stamler J., Andon N., et al. Flow stimulates endothelial cells to release a nitrosovasodilator that is potentiated by reduced thiol. Am J Physiol. 259:1990;H804-H812.
15. Stamler J., Mendelsohn M.E., Amarante P., et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 65:1989;789-795.
16. Simon D.I., Stamler J.S., Jaraki O., et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb. 13:1993;791-799.
17. Husain S., Andrews N.P., Mulcahy D., et al. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 97:1998;716-720.
18. Dakak N., Husain S., Mulcahy D.M., et al. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction and effect of L-arginine. Hypertension. 32:1998;9-15.
19. Quyyumi A.A., Dakak N., Mulcahy D., et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 29:1997;308-317.
20. Quyyumi A.A., Dakak N., Andrews N.P., et al. Nitric oxide activity in the human coronary circulation. J Clin Invest. 95:1995;1747-1755.
21. Panza J.A., Casino P.R., Kilcoyne C.M., Quyyumi A.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87:1993;1468-1474.
22. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
23. Quyyumi A.A., Dakak N., Andrews N.P., et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 92:1995;320-326.
24. Kugiyama K., Ohgushi M., Motoyama T., et al. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. Circulation. 97:1998;2299-2301.
25. Creager M.A., Roddy M.-A., Boles K., Stamler J.S. N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in-vivo. Hypertension. 29:1997;668-672.
26. Stamler J.S., Jaraki O., Osborne J., et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 89:1992;7674-7677.
27. Meister A. Selective modification of glutathione metabolism. Science. 220:1983;472-477.
28. Shan X., Aw T.Y., Jones D.P. Glutathione-dependent protection against oxidative injury. Pharmacol Ther. 47:1990;61-71.
29. Morrow J.D., Frei B., Longmire A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 332:1995;1198-1203.
30. Seth P., Fung H.-L. Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells. Biochem Pharmacol. 46:1993;1481-1486.
31. Wheatley R.M., Dockery S.P., Kurz M.A., et al. Interaction of nitroglycerin and sulfhydryl-donating compounds in coronary microvessels. Am J Physiol. 266:1994;H291-H297.
32. Kurz M.A., Lamping K.G., Bates J.N., et al. Mechanisms responsible for the heterogenous coronary microvascular response to nitroglycerin. Circ Res. 68:1991;847-855.
33. Horowitz J.D., Henry C.A., Syrjanen M.L., et al. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation. 77:1988;787-794.
34. Winniford M.D., Kennedy P.L., Wells P.J., Hillis D. Potentiation of nitroglycerin-induced coronary dilation by N-acetylcysteine. Circulation. 73:1986;138-142.
35. Boesgaard S., Poulsen H.E., Aldershvile J., et al. Acute effects of nitroglycerin depend on both plasma and intracellular sulfhydryl compound levels in vivo. Circulation. 87:1993;547-553.
36. Bates J.N., Baker M.T., Guerra R. Jr, Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol. 42:(Suppl):1991;S157-S165.
37. Gruetter D.Y., Gruetter C.A., Barry B.K., et al. Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine-inhibition by calcium, and other cations, enhancement by thiols. Biochem Pharmacol. 29:1980;2943-2950.
38. Daley W.L., Loscalzo J., Vita J.A., et al. The effect of thiol on the hemodynamic profile of nitroprusside: mechanistic implication in vivo. Circulation. 86:(Suppl I):1992;I-489.
39. DeBelder A.J., MacAllister R., Radomski M.W., et al. Effects of S-nitrosoglutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res. 28:1994;691-694.
40. Langford E.J., Brown A.S., Wainwright R.J., et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 344:1994;1458-1460.
41. Horowitz J.D., Antman E.M., Lorell B.H., et al. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation. 68:1983;1247-1253.
42. Marks D.S., Vita J.A., Folts J.D., et al. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest. 96:1995;2630-2638.
43. Vita J.A., Frei B., Holbrook M., et al. L-2-Oxothiazolidine 4 carboxylic acid improves endothelial dysfunction in patients with coronary artery disease. J Clin Invest. 101:1998;1408-1414.